According to the announcement of Magic Pharmaceuticals, the company released its 2026 semi-annual report, achieving operating income of 848 million yuan, a year-on-year decrease of 11.73%; net profit attributable to shareholders of listed companies was 21.9656 million yuan, a year-on-year decrease of 33.05%. The company's profits were not distributed or increased during the reporting period. The company's Q2 net profit was 0.09 million and Q1 net profit was 0.13 million. Based on this calculation, Q2 net profit decreased 29% month-on-month.

According to the announcement of Magic Pharmaceuticals, the company released its 2026 semi-annual report, achieving operating income of 848 million yuan, a year-on-year decrease of 11.73%; net profit attributable to shareholders of listed companies was 21.9656 million yuan, a year-on-year decrease of 33.05%. The company's profits were not distributed or increased during the reporting period. The company's Q2 net profit was 0.09 million and Q1 net profit was 0.13 million. Based on this calculation, Q2 net profit decreased 29% month-on-month.